A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)

•Twenty four percent of dogs affected with hypoadrenocorticism demonstrated autoantibodies against P450 side chain cleavage enzyme.•The autoantibody status remained consistent in most dogs, but fluctuated in some animals.•There was no relationship between autoantibody persistence and sex. Autoantibo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary immunology and immunopathology 2018-08, Vol.202, p.41-45
Hauptverfasser: Boag, Alisdair M., Christie, Michael R., McLaughlin, Kerry A., Syme, Harriet M., Graham, Peter, Catchpole, Brian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 45
container_issue
container_start_page 41
container_title Veterinary immunology and immunopathology
container_volume 202
creator Boag, Alisdair M.
Christie, Michael R.
McLaughlin, Kerry A.
Syme, Harriet M.
Graham, Peter
Catchpole, Brian
description •Twenty four percent of dogs affected with hypoadrenocorticism demonstrated autoantibodies against P450 side chain cleavage enzyme.•The autoantibody status remained consistent in most dogs, but fluctuated in some animals.•There was no relationship between autoantibody persistence and sex. Autoantibodies directed against the P450 side chain cleavage enzyme (P450scc) have been recently described in dogs affected with hypoadrenocorticism, consistent with an immune-mediated pathogenesis of this endocrinopathy. In human autoimmune Addison’s disease, autoantibodies may have a predictive value, being detectable before clinical signs developing, and have been shown to persist for a period of time after diagnosis. Furthermore, an autoantibody positive status post-diagnosis has been associated with successful remission of Addison’s disease following B-cell depletion, suggesting active immunopathology in these cases. The current study was designed to investigate changes in serum P450scc autoantibody status over time in dogs diagnosed with spontaneous hypoadrenocorticism. P450scc autoantibodies were measured using a species-specific radioimmunoprecipitation assay in an initial cohort of 213 dogs, indicating a prevalence of 24%. Thirty two of these dogs had repeat samples (n = 80 in total) available for analysis. Five dogs were consistently P450scc autoantibody positive in all samples, for up to 425 days following first sampling. Three dogs were initially autoantibody positive, then became seronegative at later time points. One dog, a 1 year old female entire standard poodle, was initially negative for P450scc autoantibodies, but seroconverted 18 months after diagnosis. The remaining 23 dogs with multiple samples available were consistently P450scc autoantibody negative. Persistence was not associated with sex (p = .673). This study demonstrates persistence of P450scc autoantibodies in a subset of dogs affected with hypoadrenocorticism and seroconversion over one year post-diagnosis. P450scc autoantibody reactivity in human autoimmune Addison’s disease has been associated with sex, with females having a higher prevalence, possibly due to P450scc expression in the ovary acting as an additional source of antigenic stimulation. However, there was no sex difference in autoantibody persistence in the dogs affected with hypoadrenocorticism. Autontibody persistence in dogs with hypoadrenocorticism might represent persistent pathology, due to residual antigenic stimulation and
doi_str_mv 10.1016/j.vetimm.2018.05.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2084338419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165242717303525</els_id><sourcerecordid>2084338419</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-f2e706b0fa87102d37149ef509a129050e6e1371f0e265fd1e14515ea08d732f3</originalsourceid><addsrcrecordid>eNp9kc2O0zAQgCMEYsvCGyDkY_eQMk7iJrkgVRV_0kpwgLPl2uPWVWIXj9NVOPEavAaPxJPgVReOnDya-cajma8oXnJYceDr18fVGZMbx1UFvFuBWAGvHxUL3rV1WYm6eVwsMibKqqnaq-IZ0REARN91T4urGqDtRN8uil8bNgS_d2kyzquBUQ5mFixTUwrKJ7cLxiExtVfOU2J6TkEfYhiRfW4EMHIGS33IRaYHVGe1R4b--5zrOWXCnthyq7wjNkyniZhVoxucio5umLIWdULD7lw6sMN8CspE9EGHmJx2NLLlxhhHwf_-8ZNYjlAR3jwvnlg1EL54eK-Lr-_eftl-KG8_vf-43dyWuoEulbbCFtY7sKprOVSmbnnToxXQK171IADXyHPSAlZrYQ1H3gguUEFn2rqy9XWxvPx7iuHbhJTk6EjjMCiPYSJZQdfUddfwPqPNBdUxEEW08hTdqOIsOch7W_IoL7bkvS0JQmZbue3Vw4RpN6L51_RXTwbeXADMe54dRknaoddoXMynkya4_0_4AweXq-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2084338419</pqid></control><display><type>article</type><title>A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Boag, Alisdair M. ; Christie, Michael R. ; McLaughlin, Kerry A. ; Syme, Harriet M. ; Graham, Peter ; Catchpole, Brian</creator><creatorcontrib>Boag, Alisdair M. ; Christie, Michael R. ; McLaughlin, Kerry A. ; Syme, Harriet M. ; Graham, Peter ; Catchpole, Brian</creatorcontrib><description>•Twenty four percent of dogs affected with hypoadrenocorticism demonstrated autoantibodies against P450 side chain cleavage enzyme.•The autoantibody status remained consistent in most dogs, but fluctuated in some animals.•There was no relationship between autoantibody persistence and sex. Autoantibodies directed against the P450 side chain cleavage enzyme (P450scc) have been recently described in dogs affected with hypoadrenocorticism, consistent with an immune-mediated pathogenesis of this endocrinopathy. In human autoimmune Addison’s disease, autoantibodies may have a predictive value, being detectable before clinical signs developing, and have been shown to persist for a period of time after diagnosis. Furthermore, an autoantibody positive status post-diagnosis has been associated with successful remission of Addison’s disease following B-cell depletion, suggesting active immunopathology in these cases. The current study was designed to investigate changes in serum P450scc autoantibody status over time in dogs diagnosed with spontaneous hypoadrenocorticism. P450scc autoantibodies were measured using a species-specific radioimmunoprecipitation assay in an initial cohort of 213 dogs, indicating a prevalence of 24%. Thirty two of these dogs had repeat samples (n = 80 in total) available for analysis. Five dogs were consistently P450scc autoantibody positive in all samples, for up to 425 days following first sampling. Three dogs were initially autoantibody positive, then became seronegative at later time points. One dog, a 1 year old female entire standard poodle, was initially negative for P450scc autoantibodies, but seroconverted 18 months after diagnosis. The remaining 23 dogs with multiple samples available were consistently P450scc autoantibody negative. Persistence was not associated with sex (p = .673). This study demonstrates persistence of P450scc autoantibodies in a subset of dogs affected with hypoadrenocorticism and seroconversion over one year post-diagnosis. P450scc autoantibody reactivity in human autoimmune Addison’s disease has been associated with sex, with females having a higher prevalence, possibly due to P450scc expression in the ovary acting as an additional source of antigenic stimulation. However, there was no sex difference in autoantibody persistence in the dogs affected with hypoadrenocorticism. Autontibody persistence in dogs with hypoadrenocorticism might represent persistent pathology, due to residual antigenic stimulation and autoimmune inflammation in the adrenal gland.</description><identifier>ISSN: 0165-2427</identifier><identifier>EISSN: 1873-2534</identifier><identifier>DOI: 10.1016/j.vetimm.2018.05.013</identifier><identifier>PMID: 30078597</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Addison Disease - immunology ; Addison Disease - veterinary ; Addison’s disease ; Animals ; Autoantibodies ; Autoantibodies - blood ; Cholesterol side-chain cleavage enzyme ; Cytochrome P-450 Enzyme System - immunology ; Dog ; Dog Diseases - immunology ; Dogs ; Female ; Hypoadrenocorticism ; Longitudinal Studies ; Male ; Ovary ; Radioimmunoassay ; Sex Factors</subject><ispartof>Veterinary immunology and immunopathology, 2018-08, Vol.202, p.41-45</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-f2e706b0fa87102d37149ef509a129050e6e1371f0e265fd1e14515ea08d732f3</citedby><cites>FETCH-LOGICAL-c408t-f2e706b0fa87102d37149ef509a129050e6e1371f0e265fd1e14515ea08d732f3</cites><orcidid>0000-0001-7133-1358 ; 0000-0001-5192-3196 ; 0000-0002-5909-2160 ; 0000-0002-0967-4031</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165242717303525$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30078597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boag, Alisdair M.</creatorcontrib><creatorcontrib>Christie, Michael R.</creatorcontrib><creatorcontrib>McLaughlin, Kerry A.</creatorcontrib><creatorcontrib>Syme, Harriet M.</creatorcontrib><creatorcontrib>Graham, Peter</creatorcontrib><creatorcontrib>Catchpole, Brian</creatorcontrib><title>A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)</title><title>Veterinary immunology and immunopathology</title><addtitle>Vet Immunol Immunopathol</addtitle><description>•Twenty four percent of dogs affected with hypoadrenocorticism demonstrated autoantibodies against P450 side chain cleavage enzyme.•The autoantibody status remained consistent in most dogs, but fluctuated in some animals.•There was no relationship between autoantibody persistence and sex. Autoantibodies directed against the P450 side chain cleavage enzyme (P450scc) have been recently described in dogs affected with hypoadrenocorticism, consistent with an immune-mediated pathogenesis of this endocrinopathy. In human autoimmune Addison’s disease, autoantibodies may have a predictive value, being detectable before clinical signs developing, and have been shown to persist for a period of time after diagnosis. Furthermore, an autoantibody positive status post-diagnosis has been associated with successful remission of Addison’s disease following B-cell depletion, suggesting active immunopathology in these cases. The current study was designed to investigate changes in serum P450scc autoantibody status over time in dogs diagnosed with spontaneous hypoadrenocorticism. P450scc autoantibodies were measured using a species-specific radioimmunoprecipitation assay in an initial cohort of 213 dogs, indicating a prevalence of 24%. Thirty two of these dogs had repeat samples (n = 80 in total) available for analysis. Five dogs were consistently P450scc autoantibody positive in all samples, for up to 425 days following first sampling. Three dogs were initially autoantibody positive, then became seronegative at later time points. One dog, a 1 year old female entire standard poodle, was initially negative for P450scc autoantibodies, but seroconverted 18 months after diagnosis. The remaining 23 dogs with multiple samples available were consistently P450scc autoantibody negative. Persistence was not associated with sex (p = .673). This study demonstrates persistence of P450scc autoantibodies in a subset of dogs affected with hypoadrenocorticism and seroconversion over one year post-diagnosis. P450scc autoantibody reactivity in human autoimmune Addison’s disease has been associated with sex, with females having a higher prevalence, possibly due to P450scc expression in the ovary acting as an additional source of antigenic stimulation. However, there was no sex difference in autoantibody persistence in the dogs affected with hypoadrenocorticism. Autontibody persistence in dogs with hypoadrenocorticism might represent persistent pathology, due to residual antigenic stimulation and autoimmune inflammation in the adrenal gland.</description><subject>Addison Disease - immunology</subject><subject>Addison Disease - veterinary</subject><subject>Addison’s disease</subject><subject>Animals</subject><subject>Autoantibodies</subject><subject>Autoantibodies - blood</subject><subject>Cholesterol side-chain cleavage enzyme</subject><subject>Cytochrome P-450 Enzyme System - immunology</subject><subject>Dog</subject><subject>Dog Diseases - immunology</subject><subject>Dogs</subject><subject>Female</subject><subject>Hypoadrenocorticism</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Ovary</subject><subject>Radioimmunoassay</subject><subject>Sex Factors</subject><issn>0165-2427</issn><issn>1873-2534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2O0zAQgCMEYsvCGyDkY_eQMk7iJrkgVRV_0kpwgLPl2uPWVWIXj9NVOPEavAaPxJPgVReOnDya-cajma8oXnJYceDr18fVGZMbx1UFvFuBWAGvHxUL3rV1WYm6eVwsMibKqqnaq-IZ0REARN91T4urGqDtRN8uil8bNgS_d2kyzquBUQ5mFixTUwrKJ7cLxiExtVfOU2J6TkEfYhiRfW4EMHIGS33IRaYHVGe1R4b--5zrOWXCnthyq7wjNkyniZhVoxucio5umLIWdULD7lw6sMN8CspE9EGHmJx2NLLlxhhHwf_-8ZNYjlAR3jwvnlg1EL54eK-Lr-_eftl-KG8_vf-43dyWuoEulbbCFtY7sKprOVSmbnnToxXQK171IADXyHPSAlZrYQ1H3gguUEFn2rqy9XWxvPx7iuHbhJTk6EjjMCiPYSJZQdfUddfwPqPNBdUxEEW08hTdqOIsOch7W_IoL7bkvS0JQmZbue3Vw4RpN6L51_RXTwbeXADMe54dRknaoddoXMynkya4_0_4AweXq-w</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Boag, Alisdair M.</creator><creator>Christie, Michael R.</creator><creator>McLaughlin, Kerry A.</creator><creator>Syme, Harriet M.</creator><creator>Graham, Peter</creator><creator>Catchpole, Brian</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7133-1358</orcidid><orcidid>https://orcid.org/0000-0001-5192-3196</orcidid><orcidid>https://orcid.org/0000-0002-5909-2160</orcidid><orcidid>https://orcid.org/0000-0002-0967-4031</orcidid></search><sort><creationdate>201808</creationdate><title>A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)</title><author>Boag, Alisdair M. ; Christie, Michael R. ; McLaughlin, Kerry A. ; Syme, Harriet M. ; Graham, Peter ; Catchpole, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-f2e706b0fa87102d37149ef509a129050e6e1371f0e265fd1e14515ea08d732f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Addison Disease - immunology</topic><topic>Addison Disease - veterinary</topic><topic>Addison’s disease</topic><topic>Animals</topic><topic>Autoantibodies</topic><topic>Autoantibodies - blood</topic><topic>Cholesterol side-chain cleavage enzyme</topic><topic>Cytochrome P-450 Enzyme System - immunology</topic><topic>Dog</topic><topic>Dog Diseases - immunology</topic><topic>Dogs</topic><topic>Female</topic><topic>Hypoadrenocorticism</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Ovary</topic><topic>Radioimmunoassay</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boag, Alisdair M.</creatorcontrib><creatorcontrib>Christie, Michael R.</creatorcontrib><creatorcontrib>McLaughlin, Kerry A.</creatorcontrib><creatorcontrib>Syme, Harriet M.</creatorcontrib><creatorcontrib>Graham, Peter</creatorcontrib><creatorcontrib>Catchpole, Brian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary immunology and immunopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boag, Alisdair M.</au><au>Christie, Michael R.</au><au>McLaughlin, Kerry A.</au><au>Syme, Harriet M.</au><au>Graham, Peter</au><au>Catchpole, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)</atitle><jtitle>Veterinary immunology and immunopathology</jtitle><addtitle>Vet Immunol Immunopathol</addtitle><date>2018-08</date><risdate>2018</risdate><volume>202</volume><spage>41</spage><epage>45</epage><pages>41-45</pages><issn>0165-2427</issn><eissn>1873-2534</eissn><abstract>•Twenty four percent of dogs affected with hypoadrenocorticism demonstrated autoantibodies against P450 side chain cleavage enzyme.•The autoantibody status remained consistent in most dogs, but fluctuated in some animals.•There was no relationship between autoantibody persistence and sex. Autoantibodies directed against the P450 side chain cleavage enzyme (P450scc) have been recently described in dogs affected with hypoadrenocorticism, consistent with an immune-mediated pathogenesis of this endocrinopathy. In human autoimmune Addison’s disease, autoantibodies may have a predictive value, being detectable before clinical signs developing, and have been shown to persist for a period of time after diagnosis. Furthermore, an autoantibody positive status post-diagnosis has been associated with successful remission of Addison’s disease following B-cell depletion, suggesting active immunopathology in these cases. The current study was designed to investigate changes in serum P450scc autoantibody status over time in dogs diagnosed with spontaneous hypoadrenocorticism. P450scc autoantibodies were measured using a species-specific radioimmunoprecipitation assay in an initial cohort of 213 dogs, indicating a prevalence of 24%. Thirty two of these dogs had repeat samples (n = 80 in total) available for analysis. Five dogs were consistently P450scc autoantibody positive in all samples, for up to 425 days following first sampling. Three dogs were initially autoantibody positive, then became seronegative at later time points. One dog, a 1 year old female entire standard poodle, was initially negative for P450scc autoantibodies, but seroconverted 18 months after diagnosis. The remaining 23 dogs with multiple samples available were consistently P450scc autoantibody negative. Persistence was not associated with sex (p = .673). This study demonstrates persistence of P450scc autoantibodies in a subset of dogs affected with hypoadrenocorticism and seroconversion over one year post-diagnosis. P450scc autoantibody reactivity in human autoimmune Addison’s disease has been associated with sex, with females having a higher prevalence, possibly due to P450scc expression in the ovary acting as an additional source of antigenic stimulation. However, there was no sex difference in autoantibody persistence in the dogs affected with hypoadrenocorticism. Autontibody persistence in dogs with hypoadrenocorticism might represent persistent pathology, due to residual antigenic stimulation and autoimmune inflammation in the adrenal gland.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30078597</pmid><doi>10.1016/j.vetimm.2018.05.013</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7133-1358</orcidid><orcidid>https://orcid.org/0000-0001-5192-3196</orcidid><orcidid>https://orcid.org/0000-0002-5909-2160</orcidid><orcidid>https://orcid.org/0000-0002-0967-4031</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0165-2427
ispartof Veterinary immunology and immunopathology, 2018-08, Vol.202, p.41-45
issn 0165-2427
1873-2534
language eng
recordid cdi_proquest_miscellaneous_2084338419
source MEDLINE; Elsevier ScienceDirect Journals
subjects Addison Disease - immunology
Addison Disease - veterinary
Addison’s disease
Animals
Autoantibodies
Autoantibodies - blood
Cholesterol side-chain cleavage enzyme
Cytochrome P-450 Enzyme System - immunology
Dog
Dog Diseases - immunology
Dogs
Female
Hypoadrenocorticism
Longitudinal Studies
Male
Ovary
Radioimmunoassay
Sex Factors
title A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A24%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20longitudinal%20study%20of%20autoantibodies%20against%20cytochrome%20P450%20side-chain%20cleavage%20enzyme%20in%20dogs%20(Canis%20lupus%20familiaris)%20affected%20with%20hypoadrenocorticism%20(Addison%E2%80%99s%20disease)&rft.jtitle=Veterinary%20immunology%20and%20immunopathology&rft.au=Boag,%20Alisdair%20M.&rft.date=2018-08&rft.volume=202&rft.spage=41&rft.epage=45&rft.pages=41-45&rft.issn=0165-2427&rft.eissn=1873-2534&rft_id=info:doi/10.1016/j.vetimm.2018.05.013&rft_dat=%3Cproquest_cross%3E2084338419%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2084338419&rft_id=info:pmid/30078597&rft_els_id=S0165242717303525&rfr_iscdi=true